Vycor Medical (VYCO) Enterprise Value Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vycor Medical | - | - | 375,153.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34.78% |
| Dec 31, 2025 | -13.59% |
| Sep 30, 2025 | 3.04% |
| Jun 30, 2025 | -7.03% |
| Mar 31, 2025 | 2.90% |
| Dec 31, 2024 | -11.71% |
| Sep 30, 2024 | -9.86% |
| Jun 30, 2024 | -13.64% |
| Mar 31, 2024 | 15.38% |
| Dec 31, 2023 | 7.91% |
| Sep 30, 2023 | 5.19% |
| Jun 30, 2023 | 6.99% |
| Mar 31, 2023 | 14.05% |
| Dec 31, 2022 | 29.07% |
| Sep 30, 2022 | 36.48% |
| Jun 30, 2022 | 39.05% |
| Mar 31, 2022 | 32.18% |
| Dec 31, 2021 | -9.85% |
| Sep 30, 2021 | 7.20% |
| Jun 30, 2021 | -4.38% |
| Mar 31, 2021 | 17.73% |
| Dec 31, 2020 | 34.48% |
| Sep 30, 2020 | 34.52% |
| Jun 30, 2020 | 41.21% |
| Mar 31, 2020 | 44.01% |
| Dec 31, 2019 | 51.92% |
| Sep 30, 2019 | 47.40% |
| Jun 30, 2019 | 53.32% |
| Mar 31, 2019 | 48.19% |
| Sep 30, 2018 | -148.87% |
| Jun 30, 2018 | -36.96% |
| Mar 31, 2018 | -44.96% |
| Dec 31, 2017 | -28.08% |
| Sep 30, 2017 | -3.62% |
| Jun 30, 2017 | -25.05% |
| Mar 31, 2017 | -6.70% |
| Dec 31, 2016 | 43.07% |
| Sep 30, 2016 | 42.61% |
| Jun 30, 2016 | 47.54% |
| Mar 31, 2016 | 11.27% |
| Dec 31, 2015 | -24.55% |
| Sep 30, 2015 | -69.77% |
| Jun 30, 2015 | -50.00% |